The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
Parker Hannifin PH
Clears both ethical standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Parker-Hannifin Corporation manufactures and sells motion and control technologies and systems for aerospace and defense, in-plant and industrial equipment, transportation, off-highway, energy, and HVAC and refrigeration…
read at $987.54
Parker Hannifin holds its Markup at $987.54.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 136 days |
| Price | $987.54 |
| Valuation | 36.44 trailing · 28.95 forward price to earnings |
| Values screen | PASS · score 85.1 |
| Beta | 1.11 |
The opportunity · what the numbers say it is worth
Our framework reads OVERVALUED — it trades above our $869.62 fair value estimate, moderate competitive moat, 10.60% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 10.60% |
| Profit margin | 16.58% |
| Debt to equity | 65.55 |
| Analyst consensus | Buy · 23 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is just 31.5% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 11.4% of assets, under the 49% limit. Pass
- Revenue purity Only 0.1% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Reliable Parts Maker Carries a Premium Tag
Picture the hydraulic lines and flight controls that keep factories humming and jets in the air. Parker Hannifin supplies those motion systems across aerospace, industry and transport, posting 11 percent revenue growth, 17 percent profit margins and 25 percent return on equity. The business earns a moderate moat and clears the ethical screen without issue.
Yet the shares trade at 28 times forward earnings, nine percent above our fair value of 869 dollars while the current price sits at 953. That leaves no margin of safety and turns the stock into an overvalued proposition despite the solid operating numbers and broad analyst buy ratings. We pass.
Cyclical end markets in aerospace and heavy equipment can swing sharply with downturns, and a high multiple leaves little room for disappointment. Currency moves and supply-chain snags add further volatility. Analysis, not advice.
| Forward P/E | 28.9x expensive even after accounting for its growth |
| Trailing P/E | 36.4x expensive — the price assumes strong growth ahead |
| Revenue growth | 10.6% steady growth |
| Profit margin | 16.6% healthy profit margins |
| Return on equity | 24.8% an exceptional return on shareholder capital |
| Debt to equity | 0.66 moderate, manageable leverage |
| Current ratio | 1.13 adequate liquidity, worth monitoring |
| Beta | 1.11 moves a little more than the market |
| Market cap | $124.5B |
| Employees | 57,950 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on PH
- › Parker-Hannifin (PH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks · 3d ago
- › Howmet Aerospace Stock And The Sound Of One Hand Clapping Trefis · 9d ago
- › The One Big Bet That Could Reignite Adobe Stock Trefis · 11d ago
- › Eli Lilly Stock And The Price Of Confidence Trefis · 12d ago
- › What You Need to Know Ahead of Parker-Hannifin's Earnings Release Barchart · 12d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in PH's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
PH trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (24 analysts) rates it buy, with a mean price target of $1034.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-22 | PAREL DINU JOHN | Officer | 4,467 | · | |
| 2026-04-22 | IVES ANGELA R | Officer | 1,563 | · | |
| 2026-04-22 | CZAJA MARK T. | Chief Technology Officer | 3,580 | · | |
| 2026-04-22 | BRACHT BEREND | Officer | 4,467 | · | |
| 2026-04-22 | BENDALI RACHID | Officer | 4,467 | · | |
| 2026-04-22 | REIDY JAY | Officer | 3,725 | · | |
| 2026-04-22 | LEONTI JOSEPH R. | General Counsel | 4,546 | · | |
| 2026-04-22 | GENTILE THOMAS C. | Officer | 2,241 | · | |
| 2026-04-22 | LEOMBRUNO TODD M. | Chief Financial Officer | 8,343 | · | |
| 2026-04-22 | PARMENTIER JENNIFER A | Chief Executive Officer | 29,808 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 8 May2026 | Dave McCormick | Republican | buy | 500K–1M |
| 5 Jun2026 | David Taylor | Republican | buy | 1K–15K |
| 30 Apr2026 | Dave McCormick | Republican | sell | 100K–250K |
| 27 May2026 | Jerry Moran | Republican | sell | 1K–15K |
| 26 May2026 | Dave McCormick | Republican | sell | 100K–250K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $874.36 | +0.4% | · | $1,004 | +0.4% |
| 2 months | $982.01 | -10.6% | $2.00 | $896 | -10.4% |
| 3 months | $900.14 | -2.5% | $2.00 | $978 | -2.2% |
| 6 months | $895.43 | -2.0% | $3.80 | $985 | -1.5% |
| 1 year | $665.15 | +32.0% | $7.40 | $1,331 | +33.1% |
| 2 years | $516.12 | +70.1% | $14.09 | $1,728 | +72.8% |
| 3 years | $344.88 | +154.6% | $20.16 | $2,604 | +160.4% |
| 5 years | $283.14 | +210.1% | $30.05 | $3,207 | +220.7% |
Historical returns from market close data. Past performance does not guarantee future results.